Table 4 Responses to statement included in Round 3 (19 respondents)
Question | Round 3 | |
|---|---|---|
Agree/neutral | Disagree | |
1. The 5-domain NPCCSS scale is the first choice for assessing clinical severity of NPC in routine clinical practice | 68% (13) | 32% (6) |
2. The 17-domain NPCCSS scale is the first choice for assessing clinical severity of NPC in clinical trial settings, prioritising the domains in the 5-domain scale (e.g. as primary endpoints) | 74% (14) | 26% (5) |
3. There is no need for a new universal scale for all settings to be developed | 74% (14) | 26% (5) |
4. Resources/training on how to apply the NPCCSS (17- and 5-domains) should be developed and provided to clinicians working in NPC | 89% (17) | 11% (2) |
5. The consensus paper is reviewed periodically to ensure that its recommendations remain accurate | 100% (19) | 0% (0) |
6. The timescale for periodic review of the consensus paper should be every 5 years | 84% (16) | 16% (3) |